Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group
- PMID: 9681857
- DOI: 10.1046/j.1365-2796.1998.00337.x
Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group
Abstract
Haemangioblastoma of the central nervous system (CNS) is the most characteristic lesion and the most common presenting manifestation of von Hippel-Lindau (VHL) disease and has a striking tendency to multiple occurrence. Its sites of predilection are the posterior fossa (cerebellum++), and the spinal cord. Haemangioblastoma may cause increased intracranial pressure and/or neurological deficits and remains the main cause of morbidity and mortality in VHL. Treatment of symptomatic haemangioblastoma remains neurosurgical and is often in emergency. Haemangioblastoma appears to be more commonly associated with VHL than previously reported and suggests that all patients with 'sporadic' haemangioblastoma should be investigated for evidence of VHL disease. From a fundamental point of view, haemangioblastoma is a benign neoplastic entity with a double, vascular and cellular differentiation. Mutational inactivation of both copies of the VHL gene plays a major role in the pathogenesis of haemangioblastoma. Over-expression of vascular endothelial growth factor (VEGF) and VEGF-receptors has been recently demonstrated in these tumours, raising the possibility of angioblastic origin, and is of very great interest in view of the direct implication of the VHL gene in negative regulation of VEGF.
Similar articles
-
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.Genes (Basel). 2021 Sep 15;12(9):1414. doi: 10.3390/genes12091414. Genes (Basel). 2021. PMID: 34573396 Free PMC article.
-
The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):758-62. doi: 10.1136/jnnp.67.6.758. J Neurol Neurosurg Psychiatry. 1999. PMID: 10567493 Free PMC article.
-
VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.Brain. 2007 Mar;130(Pt 3):836-42. doi: 10.1093/brain/awl362. Epub 2007 Jan 29. Brain. 2007. PMID: 17264095
-
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.Neurosurg Rev. 2000 Mar;23(1):1-22; discussion 23-4. doi: 10.1007/s101430050024. Neurosurg Rev. 2000. PMID: 10809480 Review.
-
[Does hemangioblastoma exist outside von Hippel-Lindau disease?].Neurochirurgie. 1994;40(3):145-54. Neurochirurgie. 1994. PMID: 7723921 Review. French.
Cited by
-
Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature.J Gastrointest Surg. 2012 Jul;16(7):1422-8. doi: 10.1007/s11605-012-1847-0. Epub 2012 Feb 28. J Gastrointest Surg. 2012. PMID: 22370733 Review.
-
Overexpression and activation of epidermal growth factor receptor in hemangioblastomas.J Neurooncol. 2010 Sep;99(2):195-200. doi: 10.1007/s11060-010-0125-9. Epub 2010 Feb 22. J Neurooncol. 2010. PMID: 20730556 Free PMC article.
-
Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients.J Med Genet. 2022 Oct;59(10):951-956. doi: 10.1136/jmedgenet-2021-108216. Epub 2021 Dec 16. J Med Genet. 2022. PMID: 34916234 Free PMC article.
-
Craniotomy for cerebellar hemangioblastoma excision in a patient with von Hippel-Lindau disease complicated by uncontrolled hypertension due to pheochromocytoma.Int J Surg Case Rep. 2015;17:96-9. doi: 10.1016/j.ijscr.2015.10.037. Epub 2015 Nov 4. Int J Surg Case Rep. 2015. PMID: 26595895 Free PMC article.
-
Intramedullary Spinal Cord Tumors: Part I-Epidemiology, Pathophysiology, and Diagnosis.Global Spine J. 2015 Oct;5(5):425-35. doi: 10.1055/s-0035-1549029. Epub 2015 Mar 31. Global Spine J. 2015. PMID: 26430598 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
